CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Samit Hirawat

Executive Vice President, Chief Medical Officer & Head of Development, Bristol Myers Squibb

Verified interview transcripts, podcast appearances, and direct quotes from Samit Hirawat, Executive Vice President, Chief Medical Officer & Head of Development at Bristol Myers Squibb. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • 2024 SAPA Annual Conference Interview with Dr. Samit Hirawat, MD., EVP, CMO of Bristol Myers Squibb

    🎥 2024 SAPA Annual Conference Interview with Dr. Samit Hirawat, MD., Executive Vice President, Chief Medical Officer and Head of Drug Development of Bristol Myers Squibb: Innovation at Speed—The Urgency of Developing Transformational Medicines Dr. Hirawat delivered a keynote speech on the prospects of innovating at speed to find cures of diseases, empathizing the company’s commitment to improving patients’ quality of life through innovative therapies. Dr. Junchi Lu, Executive Committee member of SAPA. has the pleasure talking with Dr. Hirawat on various topics after the keynote speech. Hi…

    Watch on YouTube ↗

  • Impactful Insights with Kalyani Bellamkonda & Samit Hirawat at Akshaya Patra Gala

    Kalyani Bellamkonda, Founder of GAIN Media, recently engaged in a conversation with Samit Hirawat, Chief Medical Officer of Bristol Myers Squibb at The Akshaya Patra Foundation Annual Gala Event, to discuss amplifying awareness about the impactful work Akshaya Patra has been doing for underprivileged children. Akshaya Patra, a 501(c)(3) non-profit organization, is on a mission to combat hunger and improve educational access by providing nutritious, hot meals to millions of children across India and beyond. Through its Free Mid-Day Hot Meal Program, Akshaya Patra not only fights food insecurit…

    Watch on YouTube ↗

  • Enhancing healthcare equity: diversity in healthcare research | #CriticalThinkingLive

    Clinical trials evaluate the safety and effectiveness of medicines. Ensuring that people from diverse backgrounds and geographies participate in clinical trials is therefore key to advancing health equity. People of different ages, races, ethnicities, gender and origins may react differently to certain medicines. Inclusive clinical research starts with a question: how do we ensure that the design and other criteria align with the population we intend to treat? Combined with science, a representative medicines development process is possible. Healthcare should work for everyone. This #Critica…

    Watch on YouTube ↗

  • Peter&Friends—Marking MPN Awareness Day — Industry Perspective: Infusing the patient voice is key

    Pleasure to speak with Samit Hirawat, Executive Vice President, Chief Medical Officer at Bristol Myers Squibb. He discusses the importance of MPN patients being treated with urgency, and provides hope to patients as scientists and the industry work tirelessly to identify new medicines to bring forward in the treatment of MPNs. It is great to hear the commitments being made to infuse the patient voice in every step of the drug development journey.

    Watch on YouTube ↗

  • Clinical Trials Patient Experience Summit 2020 - Samit Hirawat, BMS

    The Pharma Perspective Moving the Value Chain to a More Patient-Centric Pharma Keynote by: Samit Hirawat, M.D. Executive Vice President, Chief Medical Officer, Global Drug Development Bristol Myers Squibb

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →